Immune maturation of T lymphocytes: sequential changes in the functional specificity and apparent affinity of hapten-reactive helper T cells during an immune response.

Uki Yamashita,T. Hamaoka,Takeshi Takami,Masayasu Kitagawa

DOI: https://doi.org/10.1016/0008-8749(76)90016-2

IF: 4.178

1976-03-01

Cellular Immunology

Abstract:

What problem does this paper attempt to address?

0106 Cognitive-Emotional Features of Insomnia Phenotypes Based on Objective Sleep Duration in Young Adults

Raegan Atha,Kristina Lenker,Susan Calhoun,Jason Liao,Alexandros Vgontzas,Duanping Liao,Edward Bixler,Julio Fernandez-Mendoza

DOI: https://doi.org/10.1093/sleep/zsae067.0106

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction The association of insomnia with adverse mental health outcomes is well-established. Prior research has suggested that cognitive-emotional predisposition to mental health disorders is shared across insomnia phenotypes. However, no study to date has examined this association in insomnia phenotypes based on objective sleep duration in young adults. Methods We studied 270 young adults (median 25 years, 53% female, 24% racial/ethnic minority) from the Penn State Child Cohort who underwent a 9-hour polysomnography (PSG) recording, clinical history, and self-report surveys. Insomnia symptoms were defined as difficulties initiating or maintaining sleep, an insomnia diagnosis or complaint, and/or sleep medication use. PSG-measured short sleep duration was defined by the median of the sample (i.e., < 7-h), identifying normal sleep duration (NSD), short sleep duration (SSD), insomnia with normal sleep duration (INSD) and insomnia with short sleep duration (ISSD). Participants completed the Ford Insomnia Response to Stress Test (FIRST), Arousal Predisposition Scale (APS), Personality Inventory for DSM-5 (PID-5-BF), Pre-Sleep Arousal Scale (PSAS), and Depression, Anxiety, and Stress Scale (DASS). A multivariate general linear model tested mean differences in cognitive-emotional outcomes across the four groups, while adjusting for sex, race/ethnicity, age, waist circumference, sleep apnea, cardiometabolic disorders, medication and substance use. Results Compared to NSD or SSD, both INSD and ISSD showed significantly higher FIRST (Ps< 0.001), APS (Ps< 0.05), PID-5-BF (Ps< 0.01), PSAS (Ps< 0.001), and DASS (Ps< 0.05) scores, except in the PID-5-BF antagonism and disinhibition trait domains. SSD showed significantly higher FIRST scores compared to NSD (P< 0.05), but no other significant differences were observed on any other scale between SSD and NSD. Conclusion Sleep reactivity, cognitive-emotional arousability, internalization, and negative affectivity are trait features of insomnia, which help perpetuate its chronicity and put all phenotypes at risk of adverse mental health outcomes. These data also suggest that sleep reactivity may be a trait present in a subset of short sleepers at risk of developing insomnia. Support (if any) NIH (R01 HL136587, R01 MH118308, UL1 TR00127)

neurosciences,clinical neurology
582 Insomnia-related cognitive and behavioural factors in adolescents with delayed sleep-wake phase disorder

Forrest Tin Wai Cheung,Joey W Chan,Ngan Yin Chan,Xiao Li,J Zhang,Y K Wing,Shirley Xin Li

DOI: https://doi.org/10.1093/sleep/zsab072.580

IF: 6.313

2021-05-01

SLEEP

Abstract:Abstract Introduction Although delayed sleep-wake phase disorder (DSWPD) shares phenomenological experiences with chronic insomnia disorder, previous research on the conceptual understanding of DSWPD has been limited, with a predominant focus on its chronobiological basis. The present study examined several insomnia-related cognitive and behavioural factors in adolescents with DSWPD. Methods Twenty-five adolescents with DSWPD (age = 19.9 ± 1.6; female = 28%), 28 with chronic insomnia disorder (age = 20.4 ± 2.0; female = 61%), diagnosed according to the ICSD-3 criteria, and 25 healthy control (age = 20.4 ± 1.5; female = 68%) were included in the present study. Participants completed 7-day prospective sleep diary and actigraphy monitoring, and a battery of questionnaires on sleep and chronotype measures. Participants were also measured on hyperarousal (Pre-Sleep Arousal Scale, PSAS), sleep reactivity (Ford Insomnia Response to Stress Test, FIRST), sleep-related beliefs (Dysfunctional Beliefs and Attitudes about Sleep, DBAS-16), and sleep hygiene practices (Sleep Hygiene Practices Scale, SHPS). Analysis of covariance (ANCOVA) with gender as the covariate was used for between-group comparisons. Results Relative to healthy control group, insomnia and DSWPD group showed significantly more insomnia symptoms as measured by Insomnia Severity Index (p<.001). As compared to healthy control group, DSWPD group showed significantly more delay in circadian phase based on sleep diary and actigraphy derived mid-point of sleep, as well as greater preference towards eveningness as measured by the Morningness-Eveningness Questionnaire. DSWPD group also showed significantly more cognitive and somatic hyperarousal (p<.001, d = 1.36–2.31), sleep reactivity (p<.001, d = 1.73), dysfunctional belief about sleep (p<.001, d = 1.59), as well as poorer sleep hygiene practices (p<.001, d = 2.62), compared to healthy control. There were no significant differences in the circadian parameters, PSAS, FIRST, DBAS-16, and SHPS between DSWPD and insomnia groups. Conclusion Several insomnia-related cognitive and behavioural factors, namely hyperarousal, sleep reactivity, maladaptive beliefs about sleep, and poor sleep hygiene, are also evident in youths with DSWPD. The findings had important implications for the conceptual understanding and clinical management of DSWPD. Support (if any) This work was supported by the Seed Fund for Basic Research (University Research Committee, The University of Hong Kong) awarded to Dr. Shirley Li.

neurosciences,clinical neurology
0376 The Hyperarousal Subtype of Insomnia Disorder Is Associated with Depressive Symptoms

Dongbin Lyu,Ruiyi Qian,Yang Wang,Huajian Ma,Chengmei Yuan

DOI: https://doi.org/10.1093/sleep/zsae067.0376

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Both the hyperarousal state and depressive symptoms are associated with insomnia disorder (ID). However, it is unknown whether the characteristics of hyperarousal and depressive symptoms vary across ID subtypes. Methods This study (NCT05985512) included 136 participants aged 18 to 65, diagnosed with ID by DSM-5 criteria. We employed psychological assessments of depression using Hamilton Depression Rating Scale (HAMD-17) and one-night polysomnography (PSG) to collect psychological and electroencephalographic (EEG) characteristics including macro sleep structures and spectral features including peak frequency (frequency of the local maximum peak of mean power). Uniform Manifold Approximation and Projection (UMAP) and Variational Bayesian Gaussian Mixture Model (VB-GMM) were applied for data dimensionality reduction and cluster analysis. Dunn’s test were conducted to compare depressive and EEG features across subtypes. Significance was set at P< 0.05. Results VB-GMM clustering identified three subtypes of ID: (i) Light Sleep Subtype: This group exhibited moderate HAMD-17 scores and the least amount of N3 sleep (Dunn's test p < 0.001). (ii) Least Depression Subtype: Participants reported the lowest levels of depression and had the most N3 sleep (Dunn's test p < 0.05) with the lowest alpha and beta EEG peak frequencies during NREM sleep (Dunn's test p < 0.05). (iii) Hyperarousal with Depression Subtype: This subtype had the highest level of depressive symptoms (HAMD-17 scores, Dunn's test p < 0.001). Although the third subtype's N3 sleep was more than that in Subtype 1 (Dunn's test p < 0.001), the higher alpha and beta EEG peak frequencies (Dunn's test p < 0.05) during NREM sleep suggested a state of hyperarousal. Conclusion The subtype of ID with the highest level of depressive symptoms is associated with cortical hyperarousal. Future research is needed to study the causal relationship between insomnia and depression under the hyperarousal model. Support (if any) National Natural Science Foundation of China (81971261); Shanghai Shenkang Development Center (SHDC2020CR4074); Shanghai Science and Technology Innovation Action Plan (20Y11906600)

neurosciences,clinical neurology
0492 US Veterans with COMISA, Sleep Apnea, and Insomnia: Chronotype Prevalence and Patient-reported Outcomes

Douglas Wallace,Alexander Sweetman,William Wohlgemuth

DOI: https://doi.org/10.1093/sleep/zsae067.0492

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Among US veterans, it is unclear whether insomnia, obstructive sleep apnea (OSA), and comorbid insomnia in sleep apnea (COMISA) carry disproportionate burden to patient-reported functional outcomes (PROs). Furthermore, whether chronotypes vary among these sleep disorders groups and contribute independently to PROs has not been explored. Methods Veterans at risk for OSA evaluated at the Miami VA Sleep Center evaluated over one year. Veterans completed home polysomnography (PSG) and questionnaires (demographics, insomnia severity index [ISI], patient-reported outcomes [PROMIS-29]). OSA diagnosis was per AHI ≥ 5 on PSG while insomnia was per ISI ≥ 15. Those with COMISA fulfilled both of these criteria. Chronotype was self-reported as “morning [M]”, “more morning than evening [M>E]”, “more evening than morning [E>M]” or “evening [E]” type. Sleep group characteristics were compared by ANOVA or Chi-square. Then, regression models were constructed to determine the association of COMISA and insomnia disorder reference to OSA alone on PROMIS domain T-scores. Finally, to explore whether chronotype was associated with PROs within each sleep group, regression models stratified by sleep disorder group were constructed. Results The cohort consisted of 387 veterans (85% male, mean age 52 ± 15 years ) where 60 participants (16%) had OSA alone, 68 (18%) had insomnia alone, and 259 (67%) met COMISA criteria. Participants in the insomnia group were significantly more likely to be female, have lower mean BMI and were younger than the OSA alone and COMISA groups. The chronotype prevalence of morning, M>E, E>M, and evening were 33%, 24%, 26%, 16%, respectively. These did not vary across sleep disorder groups (p=0.15). In regression analyses, participants with insomnia alone and COMISA had worse anxiety, depression, fatigue, sleep disturbance, social disruption, physical function, and pain interference than veterans with OSA alone. However, in analyses stratified by sleep disorder groups, chronotype was not associated with any of these PROs Conclusion Veterans with COMISA and insomnia alone were more functionally impaired than those with OSA alone. However, chronotype prevalence was similar across veterans with OSA, insomnia, and COMISA and chronotype itself was not associated with PROs. Larger studies with objective measures of chronotype are needed to replicate these findings. Support (if any) None

neurosciences,clinical neurology
Evaluation of daytime sleepiness and insomnia symptoms in OSA patients with a characterization of symptom-defined phenotypes and their involvement in depression comorbidity—a cross-sectional clinical study

Agata Gabryelska,Szymon Turkiewicz,Piotr Białasiewicz,Filip Grzybowski,Dominik Strzelecki,Marcin Sochal

DOI: https://doi.org/10.3389/fpsyt.2024.1303778

IF: 4.7

2024-03-02

Frontiers in Psychiatry

Abstract:Introduction: Recent research highlights the significance of insomnia and sleepiness, shifting from obstructive sleep apnea (OSA) severity and sleep structure, in defining OSA phenotypes. Objectives: This study aimed to characterize insomnia and sleepiness associated with OSA phenotypes and assess their involvement in depression symptoms (DS) in OSA. Materials and methods: This cross-sectional, clinical study included 181 participants who underwent polysomnography (PSG) and filled out questionnaires, including the Epworth Sleepiness Scale (ESS), Insomnia Severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), and Beck Depression Index (BDI). They were categorized into phenotypes: insomnia – sleepiness (I + S; ESS ≥ 11; ISI ≥ 15; n = 20), sleepiness (S; ESS ≥ 11; ISI < 15; n = 22), insomnia (I; ESS < 11; ISI ≥ 15), and asymptomatic (A; ESS < 11; ISI<15; n=55). Results: A linear regression model for the BDI score (R 2 = 0.357, p < 0.001) included ISI score and subjective-to-objective sleep latency ratio. The ISI score was a predictive factor for mild and moderate DS [OR = 1.23 (95% CI: 1.09–1.38), p < 0.001 and OR = 1.39 (95% CI: 1.13–1.72), p = 0.002]. The I and I + S phenotypes are characterized by higher BDI scores (p < 0.001 and p = 0.02), longer subjective sleep latency (p = 0.008 and p = 0.04), and shorter subjective total sleep time (TST; p = 0.049 and p = 0.006) compared to A. Furthermore, the I and I + S groups had shorter subjective TST than S (p = 0.03 and p = 0.047). The I and I + S had higher BDI scores than A (p < 0.001 and p = 0.02, respectively) and S (p < 0.001 and p = 0.02, respectively). The I phenotype was associated with the risk of mild and moderate DS (OR = 5.61 (95% CI: 1.91–16.53), p < 0.001 and OR = 9.55 (95% CI: 1.81–50.48), p = 0.008 respectively). Moreover, the I + S phenotype presented an even greater risk for mild DS (OR = 10.29 (95% CI: 2.95–35.85), p < 0.001). Conclusion: Using clinical features for OSA phenotyping holds promise for finding OSA individuals with increased risk for DS occurrence.

psychiatry
0682 Circadian Rest/activity Rhythms Are Associated with Daytime Symptoms Among Older Adults with Insomnia

Ashley Jones,Claire Pfaeffle,Zhiwei Zhao,Avelino Verceles,Christine Johnston,Shuo Chen,Valerie Rogers,Kristine Wilkens,Adam Spira,Daniel Buysse,Emerson Wickwire

DOI: https://doi.org/10.1093/sleep/zsae067.0682

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction We investigated the association between circadian rest/activity rhythms (RARs) and daytime insomnia symptoms among older adults with insomnia. We hypothesized that: 1) RARs differ between older adults with insomnia and healthy sleepers; and 2) among older adults with insomnia, RARs are associated with daytime insomnia symptoms. Methods Older adults with insomnia (n=30) and healthy sleepers (n=33) were recruited from a tertiary academic medical center. Nonparametric RARs were derived from actigraphy data over 14 days: relative amplitude (RA), interdaily stability (IS), intradaily variability (IV), maximum ten-hour activity (M10) and minimum five-hour activity (L5). Secondary parametric RARs included amplitude, acrophase, and midline statistics of rhythm (MESOR). Daytime function was evaluated via the Daytime Insomnia Symptoms Scale (administered via smartphone 4x/day, i.e., 56 assessments per participant) and validated research questionnaires (administered once). Between-groups differences (insomnia vs healthy sleep) were evaluated using t-tests. Among individuals with insomnia, a series of 104 linear regression models examined the association between RARs and daytime symptoms. The Benjamini-Hochberg procedure for correcting false discovery rate (BH-FDR) was used to correct for multiple comparisons. Results Relative to healthy sleepers, older adults with insomnia demonstrated significantly lower RA (p=0.028,t=-2.28) and significantly higher L5 (p=0.018,t=2.48). Among older adults with insomnia, IS was positively associated with positive mood (p=0.013, t =2.67) and negatively associated with pre-sleep somatic arousal (p=0.01, t=-3.06). IV was negatively associated with DISS subscales including Alert Cognition (p=0.001, t=-3.64) and Positive Mood (p< 0.001, t=-4.15) and positively associated with Negative Mood (p< 0.001, t=4.74), and Sleepiness/fatigue (p=0.005, t=3.11), as well as validated questionnaires measuring depression (p=0.02, t=2.47), negative mood (p< 0.01, t=3.43), and pre-sleep somatic arousal (p=0.01, t=3.77). M10 was negatively associated with depression (p< 0.0,1 t=-3.29) and anxiety (p=0.01 t=-2.9). Of parametric RARs, amplitude was negatively associated with negative mood (p=0.005, t=-3.08) and depression (p=0.01, t=-2.75), and positively associated with positive mood (p=0.010, t=2.77). MESOR was negatively associated with depression (p=0.02, t=-2.48) and anxiety (p=0.01, t=-2.81). Conclusion Among older adults with insomnia, RARs were associated with daytime insomnia symptoms. Future research should examine how to optimize circadian components of therapeutic interventions in insomnia clinical care. Support (if any) Merck Investigator Studies Program (#59170).

neurosciences,clinical neurology
Radiological diagnosis of colonic polyps.

R. Marshak,A. Lindner

Abstract:
Latent profile of the insomnia severity index: A longitudinal study

Shuo Wang,Simon Theodor Jülich,Xu Lei

DOI: https://doi.org/10.1016/j.sleep.2024.02.027

IF: 4.842

2024-02-17

Sleep Medicine

Abstract:Study objectives To identify the distinct classification of insomnia symptoms and to explore their association with sleep problems and depression. Methods Latent profile analysis was used to examine patterns of insomnia symptoms in two samples. Discovery and replication samples comprised 1043 (Mean age at baseline = 18.95 ± 0.93 years, 62.2% females) and 729 (Mean age at baseline = 18.71 ± 1.02 years, 66.4% females) college students, respectively. Participants completed measures of sleep problems (insomnia symptoms, sleep quality, susceptibility to insomnia, perceived consequences of insomnia, dream recall frequency, and percentage of recurring nightmares) and other psychological variables (rumination and depression). Binary logistic regression was used to analyze the effects of different types of insomnia symptoms at baseline on sleep problems and depression two years later. Results Four classes of insomnia symptoms were identified, and classified as "non-insomnia" (class 1, 45.7%), "mild subjective symptoms but severe subjective feelings" (class 2, 23.9%), "severe subjective symptoms but mild subjective feelings" (class 3, 22.0%), and "high insomnia risk" (class 4, 8.4%), respectively. Compared with the group classified as non-insomnia group, other classifications significantly predicted insomnia two years later, only class 4 significantly predicted depression, and class 3 significantly predicted susceptibility to insomnia, after adjusting gender, insomnia, depression, and susceptibility to insomnia at baseline. Conclusions The findings highlighted the importance of identifying the patterns of insomnia symptoms, and the need for tailored intervention to improve sleep problems. Additionally, when screening for insomnia symptoms, simplified screening using Insomnia Severity Index (ISI) dimensions or items should be considered.

clinical neurology
Sleep-wake behavioral characteristics associated with depression symptoms: Findings from the Multi-Ethnic Study of Atherosclerosis

Stephen C L Lau,Gehui Zhang,Michael Rueschman,Xiaoyu Li,Michael R Irwin,Robert T Krafty,William V McCall,Elizabeth Skidmore,Sanjay R Patel,Susan Redline,Stephen F Smagula

DOI: https://doi.org/10.1093/sleep/zsae045

IF: 6.313

2024-02-23

SLEEP

Abstract:Abstract Study Objectives To help prioritize target/groups for experimental intervention studies, we characterized cross-sectional associations between 24-hour sleep/wake measures and depression symptoms; and evaluated if similar sleep/wake-depression relationships existed in people with and without higher insomnia severity. Methods Participants had ≥3 days of actigraphy data (n=1884; mean age=68.6/SD=9.1; 54.1% female). We extracted 18 sleep, activity, timing, rhythmicity, and fragmentation measures from actigraphy. We used individual and multivariable regressions with the outcome of clinically significant depression symptoms (Center for Epidemiologic Studies Depression Scale ≥16). We conducted sensitivity analyses in people with higher insomnia severity (top quartile of the Women's Health Initiative Insomnia Rating Scale total score). Results From separate models in the overall sample, the odds of having depression symptoms were higher with: later timing (e.g., activity onset time odds ratio (OR) per 1 SD=1.32; 95% confidence interval (CI): 1.16-1.50), lower rhythmicity (e.g., pseudo-F OR per 1 SD=0.75; 95% CI: 0.66-0.85), less activity (e.g., amplitude OR per 1 SD=0.83; 95% CI: 0.72-0.95), and worse insomnia (OR per 1 SD=1.48, 95% CI: 1.31-1.68). In multivariable models conducted among people with lower insomnia severity, later timing, lower rhythmicity, and higher insomnia severity were independent correlates of depression. In people with higher insomnia symptom severity, measures of later timing were most strongly associated with depression symptoms. Conclusions These correlative observations suggest that experimental studies are warranted to test if: broadly promoting 24-hour sleep/wake functioning reduces depression even in people without severe insomnia; and if advancing timing leads to depression symptom reductions in people with insomnia.

neurosciences,clinical neurology
0377 Associations of Evening-type and Insomnia Symptoms with Depressive Symptoms Among Adolescents and Young Adults

Jianyu Que,Si-jing Chen,Ngan Yin Chan,Suying Wu,Li Zhang,Yaoyi Chen,Jingrou Liu,Mingxuan Chen,Lixia Chen,Shirley Xin Li,Duoduo Lin,Farong Liu,Yun Kwok Wing

DOI: https://doi.org/10.1093/sleep/zsae067.0377

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Evening-type and insomnia symptoms are closely related to each other and independently associated with depressive symptoms, yet few studies have examined the potential interaction between these two conditions. Therefore, we aimed to examine the associations of evening-type and insomnia symptoms with depressive symptoms among Chinese young people, with a specific focus on the joint effects of the two conditions on depressive symptoms. Methods Participants aged between 12 to 25 were invited to participate in an online survey from December 15, 2022, to May 26, 2023. The reduced Morningness and Eveningness Questionnaire, Insomnia Severity Index, and Patient Health Questionnaire-9 were used to evaluate chronotypes, insomnia and depressive symptoms, respectively. Multivariate logistic regression models were used to examine the independent associations of chronotypes and insomnia symptoms with depressive symptoms, while additive interaction models were used to further explore the joint effects of chronotypes and insomnia symptoms on depressive symptoms. Results Of the 6145 eligible participants, the prevalence of evening-type and insomnia symptoms were 24.9% and 29.6%, respectively. Both evening-type (adjusted odds ratio [AdjOR]: 3.62, 95% CI: 3.19-4.11) and insomnia symptoms (AdjOR: 11.75, 95% CI: 10.26-13.47) were associated with an increased risk of depressive symptoms. In addition, the additive interaction models showed that there is an enhanced risk of depression related to interaction between evening-type and insomnia symptoms (relative excess risk of interaction [RERI]: 12.39, 95% CI: 3.62-21.17). In the subgroup analyses for adolescents (RERI: 10.37, 95% CI: 5.44-15.30) and young adults (RERI: 15.48, 95% CI: 5.49-25.46), positive interactions between evening-type and insomnia symptoms on depressive symptoms remained. Conclusion The present study provided additional evidence demonstrating the independent and joint contributions of evening-type and insomnia symptoms to depressive symptoms among young people. In particular, there is an interaction effect of evening-type and insomnia symptoms, further increasing the risk of depressive symptoms. Our findings argue the need for addressing both sleep and circadian factors in the management of depressive symptoms in young people. Support (if any) This study was supported by grants from Fujian Provincial Health technology project (No. 2022GGB015 and 2022CXB019) and Natural Science Foundation of Xiamen City (No. 3502Z20227148).

neurosciences,clinical neurology
Mediating roles of sleep quality and resilience in the relationships between chronotypes and mental health symptoms

Kean Poon,Mimi S. H. Ho,Alan P. L. Tai,Mei-Kei Leung,Meanne C. M. Chan,Way K. W. Lau

DOI: https://doi.org/10.1038/s41598-024-56688-w

IF: 4.6

2024-03-13

Scientific Reports

Abstract:Sleep and mental health are intrinsically intertwined, but not every individual with problems sleeping develops a mental health disorder. This study examined the association among chronotypes, resilience, sleep quality and mental health symptoms amongst otherwise healthy individuals. Two hundred adults ( M age = 27.75 ± 5.11, 68% female) with no previous diagnosis of mental illness were recruited and filled in a set of questionnaires measuring chronotypes, sleep quality, depression and anxiety symptoms. The findings from the path analysis showed that the morning type had a statistically significant direct effect on a range of sleep quality indices. These included better subjective sleep quality, shortened sleep latency, and fewer daytime dysfunctions, as well as a higher level of resilience. However, it did not significantly affect depression and anxiety symptoms. In addition, the morning type had statistically significant indirect effects on a higher level of resilience and fewer depression and anxiety symptoms through the mediating effect of sleep quality indices. Findings from this study support that morning type is associated with better resilience and psychological health, which is mediated through better sleep quality.

multidisciplinary sciences
The natural history of insomnia: evaluating illness severity from acute to chronic insomnia; is the first the worst?

Julia T Boyle,Knashawn H Morales,Alexandria Muench,Jason Ellis,Ivan Vargas,Michael A Grandner,Donn Posner,Michael L Perlis

DOI: https://doi.org/10.1093/sleep/zsae034

IF: 6.313

2024-02-04

SLEEP

Abstract:Abstract Study Objectives The 3P and 4P models represent illness severity over the course of insomnia disorder. The 3P model suggests that illness severity is worst during acute onset. The 4P model suggests that illness severity crescendos with chronicity. The present analysis from an archival dataset assesses illness severity with new onset illness (i.e. from good sleep [GS] to acute insomnia [AI] to chronic insomnia [CI]). Illness severity is quantified in terms of total wake time (TWT). Methods GSs (N = 934) were followed up to 1 year with digital sleep diaries, and classified as GS, AI, or CI. Data for CIs were anchored to the first of 14 days with insomnia so that day-to-day TWT was represented prior to and following AI onset. A similar graphic (+/−acute onset) was constructed for number of days per week with insomnia. GS data were temporally matched to CI data. Segmented linear mixed regression models were applied to examine the change in slopes in the AI-to-CI period compared to GS-to-AI period. Results Twenty-three individuals transitioned to AI and then CI. Average TWT rose during the first 2 weeks of AI onset (b = 1.8, SE = 0.57, p = 0.001) and was then stable for 3 months (b = −0.02, SE = 0.04, p = 0.53). Average number of affected days was stable from AI to CI (b = 0.0005, SE = 0.002, p = 0.81). That is, while there was week-to-week variability in the number of days affected, no linear trend was evident. Conclusions In our sample of CIs, primarily with middle insomnia, the average severity and number of affected days were worst with the onset of AI (worst is first) and stable thereafter.

neurosciences,clinical neurology
0319 Evaluating Illness Severity from Acute to Chronic Insomnia: Is the First the Worst?

Julia Boyle,Alexandria Muench,Knashawn Morales,Jason Ellis,Ivan Vargas,Michael Grandner,Donn Posner,Michael Perlis

DOI: https://doi.org/10.1093/sleep/zsad077.0319

IF: 6.313

2023-05-01

SLEEP

Abstract:Abstract Introduction The Spielman 3P and Perlis 4P models represent illness severity over the course of insomnia disorder. The 3P model suggests that illness severity is worst when subjects experience acute illness (as compared to the subchronic and chronic phases of the disorder). The 4P model suggests that illness severity crescendos with chronicity. The present analysis uses an archival data set to assess illness severity with new onset illness (i.e.,from Good Sleep [GS] to Acute Insomnia [AI] and from AI to Chronic Insomnia [CI]). Illness severity is quantified in terms of Total Wake Time (TWT). Number of affected days/week is a tabulation of nights/week with clinical insomnia symptoms. Methods Subjects were recruited as GSs(N=911), followed up to 1-year with digital sleep diaries, and were classified as GS, AI, or CI based on standardized criteria. Data for CI subjects were anchored to the 1st of 14 days with insomnia so that day-to-day TWT, SL, WASO, and EMA were represented for ~100 days prior-to-and-following AI onset. A similar graphic (+/-Acute onset) was constructed for number of days per week with insomnia. GS data were matched to CI subjects dates (i.e., the data were temporally tethered). Segmented linear mixed regression models were applied to examine the change in slopes in the AI-to-CI period compared to GS and AI period. Results 883 subjects remained as GSs (Mage=53.1±10.8years;35.1%female;83.0%white), while 28 indi-viduals transitioned to AI and then CI (Mage=53.6±12.6years;39.3%female;89.3%white). Average TWT rose over the course of the first 2 weeks from the AI onset(b=1.6,SE=0.52minutes,p=0.002) and then was stable for 3 months(b=-0.004,SE=0.03,p=0.91). This worsening of sleep continuity was almost entirely related to increased WASO. Average number of affected days was found to be stable from AI to CI (b=0.002,SE=0.002,p=0.20). That is, while there was week-to-week variability in the number of days affected, no linear trend was evident. Conclusion These data suggest that, in our sample of CIs with primarily middle insomnia, the average severity and number of affected days was worst with the onset of AI (worst is first) and stable thereafter. Whether this temporal trend applies equally to new onset Initial and Late insomnia remains to be determined. Analyses ongoing. Support (if any) R01AG041783

neurosciences,clinical neurology
0383 Common Pathways Between Distress and Impairment Related to Insomnia, Pain, and Stress

Harrison Dickens,Abi Vance,Claire Phelps,Veronica Floyd,Jamie Walker,Mara Egeler,Arash Assar,Ivan Vargas

DOI: https://doi.org/10.1093/sleep/zsae067.0383

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Insomnia, chronic pain, and stress are highly comorbid, contributing to significant distress and impairment. Research on measures of insomnia, such as the Insomnia Severity Index, have revealed a two-factor structure consisting of both severity of insomnia symptoms and perceived distress and impairment. Prior research suggests that this perceived distress and impairment factor may represent a cognitive vulnerability that may impact other domains, including experiences of pain and stress. Pain catastrophizing, “a negative cognitive–affective response to anticipated or actual pain” and sleep reactivity, a trait-like degree to which stress exposure disrupts sleep, are both constructs that tap into similar elements of perceived distress and impairment. This study aimed to examine associations between perceived distress and impairment from insomnia, pain catastrophizing, pain interference, and sleep reactivity. Methods Participants from an online database were asked to complete the Insomnia Severity Index (ISI), Pain Catastrophizing Scale, McGill Pain Questionnaire, PROMIS Pain Interference Questionnaire, and the Ford Insomnia Response to Stress Test. Participants (n =398) were predominantly female (79%) and White (74%). The ISI was analyzed as two separate factors (i.e., F1 or the insomnia symptoms factor = items 1-3 and F2 or the insomnia-related impairment factor = items 4-7). Results Multiple adjusted regressions revealed that perceived insomnia distress and impairment (i.e., F2) was significantly related to pain catastrophizing (t = 2.18, p = .03) and pain interference (t = 3.55, p <.001), independent of insomnia and pain severity. Sleep reactivity was also significantly related to pain catastrophizing (t = 3.71, p > .001), even after adjusting for insomnia and pain severity. Conclusion Results suggest that the perceived distress and impairment resulting from insomnia, pain, and stressful events may represent a transdiagnostic vulnerability. Future research is needed to determine whether this pattern of distress and impairment extends to objective measures, such as actigraphy. This pattern of perceived distress and impairment could represent a viable intervention target. Support (if any)

neurosciences,clinical neurology
0367 The Independent and Interactive Effects of Insomnia Symptoms and Short Sleep on Sleep Physiology

Olivia Larson,Ruda Lee,Magdy Younes,Bethany Gerardy,Allan Pack,Brendan Keenan,Philip Gehrman

DOI: https://doi.org/10.1093/sleep/zsae067.0367

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction The presence of subjective insomnia complaints with objective short sleep duration (total sleep time [TST] < 6 hours/night) has been associated with more severe health outcomes compared to insomnia or shortened sleep alone. The differential and possibly interacting effects of insomnia and shortened sleep on sleep physiology have not yet been comprehensively characterized. Methods 1,014 participants from the Sleep Apnea Global Interdisciplinary Consortium (SAGIC) without sleep apnea (apnea-hypopnea index < 5 events/hour) were included. Participants were categorized as having insomnia or good sleepers based on self-reported symptoms and as short (< 6 hours/night) or normal (≥6 hours/night) sleepers based on in-laboratory TST. Analysis of variance models adjusted for age and sex assessed the effects of insomnia, shortened sleep, and their interaction on traditional sleep architecture (percent of TST in each sleep stage), EEG power metrics, and novel odds ratio product (ORP; indexes sleep depth ranging from 0 [deep sleep] to 2.5 [full wakefulness]) metrics (average ORP in each sleep stage and ORP-9 [speed with which sleep deepens following arousal]). Results Neither insomnia status, sleep duration, nor their interaction had significant effects on the percent of TST spent in any sleep stage. The interaction between insomnia status and sleep duration was not significant for any ORP or EEG metrics. However, individuals with insomnia demonstrated lighter sleep (higher NREM ORP [p=0.02, η2=0.01], REM ORP [p =0.002, η2=0.02], and ORP-9 [p=0.0002, η2=0.03]), cortical hyperarousal (higher beta power in 14-20 Hz [p=0.0003, η2=0.03] and 20-35 Hz [p=0.001, η2=0.02]), and higher sigma power (12-16 Hz [p=0.04, η2=0.01]) compared to good sleepers. Short sleepers also demonstrated lighter REM sleep (higher ORP [p=0.0004, η2=0.03]) and cortical hyperarousal (higher beta power in 14-20 Hz [p< 0.0001, η2=0.04] and 20-35 Hz [p< 0.0001, η2=0.04]) as well as lower delta power (1-4 Hz [p=0.0009, η2=0.02]) and theta power (4-7 Hz [p< 0.0001, η2=0.05]) relative to normal sleepers. Conclusion While insomnia and shortened sleep did not influence traditional sleep architecture, they were differentially associated with alterations in sleep physiology. These more granular metrics may be useful in future investigations of potentially separable mechanisms that underlie adverse health consequences in insomnia versus shortened sleep. Support (if any)

neurosciences,clinical neurology
Insomnia symptom severity and dynamics of arousal‐related symptoms across the day

Leonie J. T. Balter,Eus J. W. van Someren,John Axelsson

DOI: https://doi.org/10.1111/jsr.14276

2024-06-26

Journal of Sleep Research

Abstract:Summary Arousal is a central component of many emotional symptoms and can contribute to insomnia. Here we assessed how the timing and fluctuating nature of arousal‐related symptoms over the course of the day relate to insomnia symptom severity. In this study, 361 participants (M age = 31.9 years, 282 women, 77 men, 2 non‐binary individuals) completed the Insomnia Severity Index to assess severity of insomnia symptoms, followed by repeated ratings of anxiety or nervousness, stress, sleepiness, and feeling down via their mobile phone between ~08:00 hours and 00:00 hours across 1 day. Measures of dynamics included: mean levels across the day; variation (standard deviation); instability (mean squared successive differences); and resistance to change/inertia (first‐order autocorrelation). Time‐of‐day patterns were modelled using generalized additive mixed effects models. Insomnia symptom severity (mean Insomnia Severity Index = 9.1, SD = 5.2, range 0–25) was associated with higher mean levels of all arousal‐related symptoms, and increased instability and variation throughout the day in anxiety or nervousness, stress, and feeling down. Resistance to change (inertia) was not associated with insomnia symptom severity. Generalized additive mixed effects analyses showed that while individuals with more severe insomnia symptoms had elevated symptoms across the entire day, they were especially more anxious or nervous and sleepy in the early morning (~08:00 hours), anxious or nervous, stressed and sleepy in the late afternoon/early evening (~16:00 hours–21:00 hours), and anxious or nervous and stressed in the late evening (~22:00 hours). Remarkably, higher arousal occurred in the presence of high subjective sleepiness. Together these results indicate that insomnia symptom severity is associated with problems with daytime and evening arousal regulation.

neurosciences,clinical neurology
0966 Mood in OSA Patients with Different Chronotypes with and Without Chronic Pain

Amberlee Weber,Jeremy Weingarten,Boris Dubrovsky,John Cunningham

DOI: https://doi.org/10.1093/sleep/zsae067.0966

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Mood has been related to chronotype, OSA and pain, although no studies have examined these three variables simultaneously. This study analyzes depression symptoms in relationship to self-reported sleep timing, PSG-determined AHI and the presence of chronic pain conditions (CPC) in patients referred for OSA evaluation. Methods From patients tested between 08/2017 and 04/2021, 360 (210 women) were selected based on self-reported sleep time criteria, no shift work, no significant cardiac, pulmonary, neurological, endocrine or psychiatric history except depression/anxiety; 78 had CPC (e.g., fibromyalgia, arthritis, sciatica, musculoskeletal pain and similar). Self-reported sleep times defined typical chronotype (TC, asleep 10pm-12am, wake-up 6-9am), early and late chronotypes (EC, LC, earlier or later than TC); those not clearly meeting these criteria or reporting < 6hr or >10hr of usual sleep were excluded. The Center for Epidemiologic Studies Depression Scale-Revised (CESDR) was an outcome; explanatory variables were AHI, chronotypes (EC, TC, LC), CPC; covariates were age, sex, BMI. Results EC (n=115), TC (n=163) and LC (n=82) were unrelated to CPC (chi-square=1.1, p=0.58). Older age (M=48.5±15.7) was predictive of lower CESDR (F=17.5, p< 0.001). AHI (M=14.6±21.0) was unrelated to CESDR (F=1.6, p=0.21) and did not interact with CPC or chronotypes. CPC presence predicted higher CESDR (F=8.1, p=0.004). Chronotypes predicted CESDR (F=7.8, p< 0.001) without significant interaction with CPC. LC/CPC-absent group had higher CESDR (M=20.7±18.9) relative to EC/CPC-absent (M=11.5±11.3, p< 0.001) and TC/CPC-absent (M=10.1±10.6, p< 0.001, Bonferroni post-hoc). Among CPC-present patients, CESDR did not significantly differ between EC (M=17.5±14.5), TC (M=16.3±10.3) and LC (M=22.9±17.3). Conclusion In this sample, there was no relationship between OSA and depression symptoms. In patients without CPC, late self-reported sleep time was associated with higher depression symptoms, relative to early and typical sleep times. However, in patients with CPC, CESDR scores did not reach significant difference between chronotypes, apparently due to the overall elevation of depression symptoms in these patients. Support (if any) none

neurosciences,clinical neurology
The natural history of insomnia: acute insomnia and first-onset depression

Jason G Ellis,Michael L Perlis,Célyne H Bastien,Maria Gardani,Colin A Espie

DOI: https://doi.org/10.5665/sleep.3316

IF: 6.313

2014-01-01

SLEEP

Abstract:Study objectives: While many studies have examined the association between insomnia and depression, no studies have evaluated these associations (1) within a narrow time frame, (2) with specific reference to acute and chronic insomnia, and (3) using polysomnography. In the present study, the association between insomnia and first-onset depression was evaluated taking into account these considerations. Design: A mixed-model inception design. Setting: Academic research laboratory. Participants: Fifty-four individuals (acute insomnia [n = 33], normal sleepers [n = 21]) with no reported history of a sleep disorder, chronic medical condition, or psychiatric illness. Interventions: N/A. Measurements and results: Participants were assessed at baseline (2 nights of polysomnography and psychometric measures of stress and mood) and insomnia and depression status were reassessed at 3 months. Individuals with acute insomnia exhibited more stress, poorer mood, worse subjective sleep continuity, increased N2 sleep, and decreased N3 sleep. Individuals who transitioned to chronic insomnia exhibited (at baseline) shorter REM latencies and reduced N3 sleep. Individuals who exhibited this pattern in the transition from acute to chronic insomnia were also more likely to develop first-onset depression (9.26%) as compared to those who remitted from insomnia (1.85%) or were normal sleepers (1.85%). Conclusion: The transition from acute to chronic insomnia is presaged by baseline differences in sleep architecture that have, in the past, been ascribed to Major Depression, either as heritable traits or as acquired traits from prior episodes of depression. The present findings suggest that the "sleep architecture stigmata" of depression may actually develop over the course transitioning from acute to chronic insomnia.
10-year Stability of an Insomnia Sleeper Phenotype and Its Association with Chronic Conditions

Soomi Lee,Claire E. Smith,Meredith L. Wallace,Orfeu M. Buxton,David M. Almeida,Sanjay R. Patel,Ross Andel

DOI: https://doi.org/10.1097/psy.0000000000001288

2024-02-16

Psychosomatic Medicine

Abstract:Abstract Objective To identify distinct sleep health phenotypes in adults, examine transitions in sleep health phenotypes over time and subsequently relate these to the risk of chronic conditions. Methods A national sample of adults from the Midlife in the United States study ( N = 3,683) provided longitudinal data with two timepoints (T1:2004-2006, T2:2013-2017). Participants self-reported on sleep health (regularity, satisfaction, alertness, efficiency, duration) and the number and type of chronic conditions. Covariates included age, sex, race, education, education, partnered status, number of children, work status, smoking, alcohol, and physical activity. Results Latent transition analysis identified four sleep health phenotypes across both timepoints: good sleepers , insomnia sleepers , weekend catch-up sleepers , and nappers . Between T1 to T2, the majority (77%) maintained their phenotype, with the nappers and insomnia sleepers being the most stable. In fully adjusted models with good sleepers at both timepoints as the reference, being an insomnia sleeper at either timepoint was related to having an increased number of total chronic conditions by 28-81% at T2, adjusting for T1 conditions. Insomnia sleepers at both timepoints were at 72-188% higher risk for cardiovascular disease, diabetes, depression, and frailty. Being a napper at any timepoint related to increased risks for diabetes, cancer, and frailty. Being a weekend catch-up sleeper was not associated with chronic conditions. Those with lower education and unemployed were more likely to be insomnia sleepers ; older adults and retirees were more likely to be nappers . Conclusion Findings indicate heightened risk of chronic conditions involved in suboptimal sleep health phenotypes, mainly insomnia sleepers.

psychiatry,psychology, multidisciplinary
Discrepancy Between Desired Time in Bed and Desired Total Sleep Time, Insomnia, Depression, and Dysfunctional Beliefs About Sleep Among a Clinical Sample of Patients With Insomnia

Sohyeong Kim,Eulah Cho,Hayun Choi,Seockhoon Chung

DOI: https://doi.org/10.30773/pi.2024.0043

2024-09-25

Psychiatry Investigation

Abstract:Objective This study investigated whether the discrepancy between desired time in bed and desired total sleep time (DBST) index could be a meaningful indicator for assessing insomnia severity in a clinical sample of patients with insomnia. Furthermore, we sought to identify the mediators of the association between DBST and insomnia severity in individuals with insomnia.Methods We collected the medical records of 127 patients with insomnia. Each participant’s DBST index was calculated using sleep indices, including time and duration variables. Psychological symptoms were investigated using the Insomnia Severity Index (ISI), Patients Health Questionnaire-9 items (PHQ-9), Generalized Anxiety Disorder-7, Dysfunctional Beliefs and Attitudes about Sleep-16 items (DBAS-16), and Epworth Sleepiness Scale.Results The DBST index was significantly correlated with the ISI (r=0.20, p<0.05), desired total sleep time (r=-0.52, p<0.001), and desired time in bed (r=0.32, p<0.01). Linear regression analysis revealed that insomnia severity was associated with age (β=-0.18, p=0.018), DBST (β=0.23, p=0.003), PHQ-9 (β=0.23, p=0.031), and DBAS-16 (β=0.42, p<0.001). The DBST directly influenced insomnia severity, although indirect effects of mediators were not significant.Conclusion The DBST index directly influenced insomnia severity regardless of the mediating effects of psychological factors among a clinical sample of patients with insomnia. This finding implies that the DBST index can be a simple measure of insomnia severity, even among patients with insomnia.

psychiatry

Immune maturation of T lymphocytes: sequential changes in the functional specificity and apparent affinity of hapten-reactive helper T cells during an immune response.

0106 Cognitive-Emotional Features of Insomnia Phenotypes Based on Objective Sleep Duration in Young Adults

582 Insomnia-related cognitive and behavioural factors in adolescents with delayed sleep-wake phase disorder

0376 The Hyperarousal Subtype of Insomnia Disorder Is Associated with Depressive Symptoms

0492 US Veterans with COMISA, Sleep Apnea, and Insomnia: Chronotype Prevalence and Patient-reported Outcomes

Evaluation of daytime sleepiness and insomnia symptoms in OSA patients with a characterization of symptom-defined phenotypes and their involvement in depression comorbidity—a cross-sectional clinical study

0682 Circadian Rest/activity Rhythms Are Associated with Daytime Symptoms Among Older Adults with Insomnia

Radiological diagnosis of colonic polyps.

Latent profile of the insomnia severity index: A longitudinal study

Sleep-wake behavioral characteristics associated with depression symptoms: Findings from the Multi-Ethnic Study of Atherosclerosis

0377 Associations of Evening-type and Insomnia Symptoms with Depressive Symptoms Among Adolescents and Young Adults

Mediating roles of sleep quality and resilience in the relationships between chronotypes and mental health symptoms

The natural history of insomnia: evaluating illness severity from acute to chronic insomnia; is the first the worst?

0319 Evaluating Illness Severity from Acute to Chronic Insomnia: Is the First the Worst?

0383 Common Pathways Between Distress and Impairment Related to Insomnia, Pain, and Stress

0367 The Independent and Interactive Effects of Insomnia Symptoms and Short Sleep on Sleep Physiology

Insomnia symptom severity and dynamics of arousal‐related symptoms across the day

0966 Mood in OSA Patients with Different Chronotypes with and Without Chronic Pain

The natural history of insomnia: acute insomnia and first-onset depression

10-year Stability of an Insomnia Sleeper Phenotype and Its Association with Chronic Conditions

Discrepancy Between Desired Time in Bed and Desired Total Sleep Time, Insomnia, Depression, and Dysfunctional Beliefs About Sleep Among a Clinical Sample of Patients With Insomnia